Global Burden of Disease Findings affecting Health Spending - Projections and Forecasts towards 2050

Mihajlo (Michael) Jakovljevic, MD, PhD, MAE, University of Kragujevac, Serbia

Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE is a Top-Notch expert in the Economics of Global Health. This is witnessed with а 20 years long track record of service on behalf of various UN bodies and leading multilateral agencies such as UNESCO, WHO, GBD Project, European Commission, SNSF, JSPS etc. His primary focus of interest remains on health financing and affordability issues in the Global South's LMICs countries and the Emerging Markets. Being a professional health economist and a clinical pharmacology physician, his work is largely applicable to sustainable healthcare investment from the perspective of governing authorities, pharmaceutical and medical device industries. 
As of 2018, by the decision of WHO Director Regional, he was appointed top-tier EACHR Committee Member with WHO Regional Office for Europe in Copenhagen, Denmark. In 2021 he was elected UNESCO – TWAS Ordinary Fellow in the leading UN forum for Sustainable Development of the Global South. Academia Europaea, London, UK elected him 2022 as the first national representative to the Section Clinical and Veterinary Medicine composed of almost 800 members from all of the European continent. So far he was holding Visiting / Affiliated positions at Hosei University Tokyo, (Institute for Comparative Economic Studies / Japanese National Center for Population Aging); CHTF IHME University of Washington, USA; Health Economics Department, Lund University, Sweden; Vienna Medical University, Austria, Ghent University, Belgium etc. For his deeds and professional standing, in spring 2015 he was the only ever nominated candidate for IHEA *(International Health Economics Association) Board of Directors Elections, based in Eastern Europe. 

Hao Hu, PhD, University of Macau, China

Hao Hu is a professor of biomedical data science and medicinal administration at the Institute of Chinese Medical Sciences and the Faculty of Health Sciences at the University of Macau. He is the author of five books and has contributed over 300 articles to peer-reviewed journals. His research interests encompass bioinformatics and computational drug discovery, pharmacoeconomics and pharmacoepidemiology, and pharmaceutical industry and policy. Through his work, he has produced pharmacological, clinical, and policy evidence to address various health conditions, including cancer, diabetes, obesity, NASH (non-alcoholic steatohepatitis), and COPD (chronic obstructive pulmonary disease). Recently, he has been particularly interested in utilizing advanced data science techniques in biomedicine and Chinese medicine, especially regarding rare cancers. 

This Collection welcomes submission of original research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Global Burden of Disease Findings affecting Health Spending - Projections and Forecasts towards 2050" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.